Jiangsu Hengrui Pharmaceuticals (600276) Announces Share Repurchase and Updated Share Figures

Bulletin Express01-29

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (600276) issued a Next Day Disclosure Return dated 29 January 2026, highlighting adjustments to its issued shares and treasury shares resulting from a repurchase of A shares.

On 29 January 2026, 371,600 A shares were repurchased for the A Share Employee Stock Ownership Schemes at prices ranging from RMB 56.10 to RMB 58.07, with an aggregate payment of approximately RMB 21.07 million. Following this transaction, the number of issued shares excluding treasury shares stands at 6,374,716,724. Treasury shares increased to 4,285,550, and the total issued shares remain 6,379,002,274.

The announcement confirms compliance with relevant regulatory and legal requirements. No additional share redemptions or cancellations were reported. The disclosed figures reflect the company’s updated share structure as of the closing balance on 29 January 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1114797028?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-29 16:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1114797028","market":"us","top_or_hot":-1,"title":"Jiangsu Hengrui Pharmaceuticals (600276) Announces Share Repurchase and Updated Share Figures","media":"Bulletin Express","content":"<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (600276) issued a Next Day Disclosure Return dated 29 January 2026, highlighting adjustments to its issued shares and treasury shares resulting from a repurchase of A shares.</p>\n<p>On 29 January 2026, 371,600 A shares were repurchased for the A Share Employee Stock Ownership Schemes at prices ranging from RMB 56.10 to RMB 58.07, with an aggregate payment of approximately RMB 21.07 million. Following this transaction, the number of issued shares excluding treasury shares stands at 6,374,716,724. Treasury shares increased to 4,285,550, and the total issued shares remain 6,379,002,274.</p>\n<p>The announcement confirms compliance with relevant regulatory and legal requirements. No additional share redemptions or cancellations were reported. The disclosed figures reflect the company’s updated share structure as of the closing balance on 29 January 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jiangsu Hengrui Pharmaceuticals (600276) Announces Share Repurchase and Updated Share Figures</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJiangsu Hengrui Pharmaceuticals (600276) Announces Share Repurchase and Updated Share Figures\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-01-29 16:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (600276) issued a Next Day Disclosure Return dated 29 January 2026, highlighting adjustments to its issued shares and treasury shares resulting from a repurchase of A shares.</p>\n<p>On 29 January 2026, 371,600 A shares were repurchased for the A Share Employee Stock Ownership Schemes at prices ranging from RMB 56.10 to RMB 58.07, with an aggregate payment of approximately RMB 21.07 million. Following this transaction, the number of issued shares excluding treasury shares stands at 6,374,716,724. Treasury shares increased to 4,285,550, and the total issued shares remain 6,379,002,274.</p>\n<p>The announcement confirms compliance with relevant regulatory and legal requirements. No additional share redemptions or cancellations were reported. The disclosed figures reflect the company’s updated share structure as of the closing balance on 29 January 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01276","symbol_name":"恒瑞医药","start_time":0,"source_url":"","article_id":"1114797028","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1114797028","pubTimestamp":1769676363,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (600276) issued a Next Day Disclosure Return dated 29 January 2026, highlighting adjustments to its issued shares and treasury shares resulting from a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01276":"恒瑞医药"},"translate_title":"江苏恒瑞医药(600276)公布回购股份及更新股份数字","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01276":1},"content_text":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (600276) issued a Next Day Disclosure Return dated 29 January 2026, highlighting adjustments to its issued shares and treasury shares resulting from a repurchase of A shares.\nOn 29 January 2026, 371,600 A shares were repurchased for the A Share Employee Stock Ownership Schemes at prices ranging from RMB 56.10 to RMB 58.07, with an aggregate payment of approximately RMB 21.07 million. Following this transaction, the number of issued shares excluding treasury shares stands at 6,374,716,724. Treasury shares increased to 4,285,550, and the total issued shares remain 6,379,002,274.\nThe announcement confirms compliance with relevant regulatory and legal requirements. No additional share redemptions or cancellations were reported. The disclosed figures reflect the company’s updated share structure as of the closing balance on 29 January 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1114797028","isCrawlerRequest":true}